Stock listing
NASDAQ:SURF Surface Oncology Inc Stock
Follow Surface Oncology Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SURF
$1.07 USD
Close on Sep 12, 2023 · No longer trades
- Lowest – highest close
- $0.57 – $17.83 USDSince Apr 19, 2018 · lowest Apr 27, 2023 · highest Jul 9, 2018
Delisted NASDAQ:SURF no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SURF
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Surface Oncology Inc on 6ix
- Calls
- 1 call with a replay · 1 with a transcript · latest Jun 4, 2021
- Decks
- 5 decks · latest Nov 2, 2022
Events
| Call | When | Status |
|---|---|---|
| Surface Oncology (SURF) Q1 2021 Earnings Call | Fri, Jun 04, 2021 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (November 2022) | Corporate update | 14 slides | Nov 2, 2022 |
| Technical Presentation (June 2021) | Technical | 25 slides | Jun 4, 2021 |
| Investor Presentation (January 2020) | Investor deck | 39 slides | Jan 13, 2020 |
| Investor Day (November 2019) | Investor day | 76 slides | Nov 18, 2019 |
| JP Morgan Healthcare Conference January 2019 | Conference | 18 slides | Jan 7, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Laurie Stelzer Other companies: MBX Biosciences, Inc. (Director · Since at least Jan 20, 2026); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Spyre Therapeutics, Inc. (Chair of the Audit Committee · Since at least Nov 22, 2023); PMV Pharmaceuticals, Inc. (Chair, Board of Directors · Since at least Jun 2, 2022) | Director · Jun 8, 2022 – Jun 8, 2022 · Past |
| David Grayzel Other companies: Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Jade Biosciences, Inc. (Director · Feb 1, 2021 – Jun 5, 2024 · Past) | Director · Apr 18, 2018 – Sep 8, 2023 · Past |
| Geoff McDonough Other companies: Generation Bio Co (Director · Since at least Jun 11, 2020); Third Harmonic Bio Inc. (Director · Mar 27, 2024 – Mar 27, 2024 · Past) | Director · Jun 5, 2019 – Jun 8, 2021 · Past |
| Jeff Goater Other companies: LogicBio Therapeutics Inc (Director · Dec 10, 2020 – Nov 16, 2022 · Past); Vaccinex, Inc. (Director · Aug 9, 2018 – May 11, 2021 · Past) | Director · Apr 18, 2018 – Sep 8, 2023 · Past |
| Carsten Brunn Other companies: Cartesian Therapeutics, Inc. (President, Chief Executive Officer, and Chairman, Board of Directors · Since at least Dec 1, 2018) | Director · Jun 28, 2022 – Jun 28, 2022 · Past |
| Ramy Ibrahim Other companies: 2Seventy Bio Inc (Director · Jun 8, 2022 – Jun 13, 2023 · Past) | Director · Jun 8, 2022 – Jun 8, 2022 · Past |
| Chandra Adams | Deputy GC · Oct 27, 2022 – Sep 8, 2023 · Past |
| Jessica Fees | Chief Financial Officer · Aug 3, 2022 – Sep 8, 2023 · Past |
| Liisa I Nogelo | Chief Legal Officer · Jul 23, 2018 – Jul 21, 2021 · Past |
| Wendy Dwyer | Chief Business Officer · Apr 1, 2019 – Feb 28, 2020 · Past |
Log in to ask 6ix AI your own questions about Surface Oncology Inc.